Filing Details

Accession Number:
0001171843-15-006796
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-12-14 17:00:57
Reporting Period:
2015-12-01
Filing Date:
2015-12-14
Accepted Time:
2015-12-14 17:00:57
Original Submission Date:
2015-12-04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314282 C Don Stark C/O Immunomedics, Inc.
300 American Road
Morris Plains NJ 07950
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-01 10,000 $1.59 50,450 No 4 M Direct
Common Stock Disposition 2015-12-01 5,100 $3.16 45,350 No 4 S Direct
Common Stock Acquisiton 2015-12-01 10,664 $0.00 56,014 No 4 M Direct
Common Stock Disposition 2015-12-01 4,266 $0.00 51,748 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Per Share Stock Options (right to buy) Disposition 2015-12-01 10,000 $0.00 10,000 $1.59
Common Stock, Par Value $0.01 Per Share Restricted Stock Units Disposition 2015-12-01 10,664 $0.00 10,664 $0.00
Common Stock, Par Value $0.01 Per Share Stock Options (right to buy) Acquisiton 2015-12-02 28,821 $0.00 28,821 $3.11
Common Stock, Par Value $0.01 Per Share Restricted Stock Units Acquisiton 2015-12-02 14,469 $0.00 14,469 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-12-03 No 4 M Direct
0 No 4 M Direct
28,821 2022-12-02 No 4 A Direct
14,469 No 4 A Direct
Footnotes
  1. Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
  2. The purpose of this amendment is to correct the number of shares withheld to satisfy the tax withholding obligation of the reporting person reported in the Form 4 filed on December 4, 2015.
  3. The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
  4. The stock options are fully vested on the date of grant.
  5. Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.